There were 560 press releases posted in the last 24 hours and 161,728 in the last 365 days.

Gene therapy: Consumption, Demand, Sales, Competitor and Forecast 2016 – 2021

Wise.Guy.

Gene therapy Global Market 2016 Analysis and Forecast to 2021

PUNE, INDIA, October 19, 2016 /EINPresswire.com/ -- Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/668870-united-states-gene-therapy-forecast-to-2021

Scope of the Report:
This report focuses on the Gene Therapy Sales in United States market. This report categorizes the market based on manufacturers, type and application.
Market Segment by Manufacturers, this report covers
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene

Market Segment by Type, covers
Ex Vivo
In Vivo

Market Segment by Applications, can be divided into
Cancer Diseases
Monogenic Diseases
Infectious Diseases
Cardiovascular Diseases
Other

There are 11 Chapters to deeply display the United States Gene Therapy Sales market.

Chapter 1, to describe Gene Therapy Sales Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Gene Therapy Sales, with sales, revenue, and price of Gene Therapy Sales, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4 and 5, to show the market of Gene Therapy Sales by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 6, Gene Therapy Sales market forecast, by type and application, with sales and revenue, from 2016 to 2021;

Chapter 7, to analyze the Gene Therapy Sales market development potential except United States, covering China, Southeast Asia, India, Latin America etc.

Chapter 8, 9, 10 and 11, to describe sales channel, distributors, traders, dealers, market effect factors, appendix and data source.

Table of Contents
1 Market Overview (Market Segment, Status and Outlook)
1.1 Gene Therapy Sales Introduction
1.2 United States Gene Therapy Sales Market Analysis by Type
1.2.1 Ex Vivo
1.2.2 In Vivo
1.3 United States Gene Therapy Sales Market Analysis by Applications
1.3.1 Cancer Diseases
1.3.2 Monogenic Diseases
1.3.3 Infectious Diseases
1.3.4 Cardiovascular Diseases
1.3.5 Other
1.4 United States Market Gene Therapy Sales Overview
1.4.1 United States Gene Therapy Sales Development Status and Outlook
1.4.2 Market Opportunities
1.4.3 Market Risk
1.4.4 Market Driving Force
2 Manufacturers Profiles
2.1 Bluebird Bio
2.1.1 Business Overview
2.1.2 Gene Therapy Sales Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.2 Bluebird Bio Gene Therapy Sales Sales, Price, Revenue, Gross Margin and Market Share
2.2 Sangamo
2.2.1 Business Overview
2.2.2 Gene Therapy Sales Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.2 Sangamo Gene Therapy Sales Sales, Price, Revenue, Gross Margin and Market Share
2.3 Spark Therapeutics
2.3.1 Business Overview
2.3.2 Gene Therapy Sales Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.2 Spark Therapeutics Gene Therapy Sales Sales, Price, Revenue, Gross Margin and Market Share
2.4 Dimension Therapeutics
2.4.1 Business Overview
2.4.2 Gene Therapy Sales Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.2 Dimension Therapeutics Gene Therapy Sales Sales, Price, Revenue, Gross Margin and Market Share

Access Report @ https://www.wiseguyreports.com/reports/668870-united-states-gene-therapy-forecast-to-2021


Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here